Zehra Buşra Özbolat

Dr. Zehra Buşra Özbolat

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 February 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
MPMehmet Akif Parlar
Mehmet Akif Parlar
HMHakan Mutlu
Hakan Mutlu
BDBetül Doğantekin
Betül Doğantekin
IMIsmail Serhat Musaoglu
Ismail Serhat Musaoglu
NANisa Albayrakoglu
Nisa Albayrakoglu
MKMustafa Kaplan
Mustafa Kaplan
Background/Objectives: It has been shown that the use of statins in patients with type 2 diabetes mellitus (T2DM) worsens hyperglycemia and hemoglobin A1c levels but may help in the preservation of pancreatic β-cell function. The potential role of a high pancreatic fat fraction (PFF) in this process has not yet been clarified. This study aimed to investigate whether the liver fat fraction (LFF) and PFF in T2DM patients is affected by statin therapy. Methods: This cross-sectional study involved a total of 140 T2DM patients, including both those who were receiving (n = 70) and those who were not receiving (n = 70) statin therapy. The mapping of the LFF and PFF utilizing the IDEAL-IQ sequence was conducted in magnetic resonance imaging. Results: In T2DM patients who used statins, the median PFF was higher compared to those who did not use statins (8.4 vs. 6.2%, p = 0.021), while the median LFF was found to be similar (8.4 vs. 8.9, p = 0.572). Variations in PFF were associated with the use of various statins (non-statin group: 6.2 vs. atovastatin: 8.7 vs. rosuvastatin: 3.2 vs. pitavastatin: 9.2, p = 0.004). The multivariable regression analysis indicated that insulin usage decreased log(LFF) by a factor of 0.16-fold (ꞵ ± SE = −0.16 ± 0.05, p = 0.010), and rosuvastatin usage reduced log(PFF) by 0.16-fold (ꞵ ± SE = −0.16 ± 0.07, p = 0.025), irrespective of other risk factors. Furthermore, the use of atorvastatin (ꞵ ± SE = 0.17 ± 0.06, p = 0.011) and pitavastatin (ꞵ ± SE = 0.19 ± 0.07, p = 0.008) were independently associated with an increase in log(PFF). Conclusions: In patients with T2DM, statin use did not show a significant effect on the liver fat fraction, but it caused differences in the pancreatic fat fraction. The observation of a lower pancreatic fat fraction in patients taking a rosuvastatin and atorvastatin dose of 40 mg/day suggests that different types and doses of statins may have varying effects on pancreatic fat accumulation.

31 May 2022 in Izmir Democracy University Health Sciences Journal
Verified
Journal Article
Closed access
PDF file
HAHulya Abali
Hulya Abali
TZTugba Mandal Zi̇rEk
Tugba Mandal Zi̇rEk
FAFatma Tokgöz Akyil
Fatma Tokgöz Akyil
ZÖZehra Buşra Özbolat
Zehra Buşra Özbolat
AKAslı KOCAOĞLU
Aslı KOCAOĞLU
SOSeda Tural Onur
Seda Tural Onur
Central and peripheral types of squamous cell carcinoma (SQCC) are classified in different categories due to different clinical-pathological features. Peripheral SQCC, according to histological pattern; it is classified into three subgroups as alveolar space-filling type, expanding type and combined type. Of these three subtypes, alveolar space-filling neither causes lymphatic vessel invasion nor lymph node metastasis and has the best prognosis. Herein, we present a rare case of squamous cell carcinoma that did not metastasize at two and a half years years from initial diagnosis.

6 August 2026 in BMC Pulmonary Medicine
Verified
Journal Article
Open access
PDF file
ZÖZehra Buşra Özbolat
Zehra Buşra Özbolat
MOMediha Gonenc Ortakoylu
Mediha Gonenc Ortakoylu
HÜHalide Nur Ürer
Halide Nur Ürer
MUMehmet Atilla Uysal
Mehmet Atilla Uysal
BBBelma Akbaba Bağcı
Belma Akbaba Bağcı
UIUmut İlHan
Umut İlHan
Differentiating sarcoidosis from tuberculosis in patients with mediastinal and/or hilar granulomatous lymphadenopathy remains challenging due to overlappin